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1158-71 Cardiac-Specific Gain-of-Function Mutation in the 
Natriuretic Peptide A Receptor Is Associated With 
Improved Diastolic Function in Presence and Absence 
of Pressure Overload Hypertrophy 
1158-73 Altered Angiotensin II-Induced Activation of 
Intracellular Signalling Pathways in Failing Human 
Ventricular Myocytes 
Allison M. Pritchett. Maria L. Valencik. John A. McDonald, Gerald E. Harder% Margaret 
M. Redfield. Mayo Clinic Foundation, Rochester, MN, Salt Lake City Veterans 
Administration Medical Center, Salt Lake City, UT 
Pietro A. Modesti Alessandra Modesti, Simone Vanni, Thomas Toscano, llxa Cecioni, 
Tania Gamberi, lacopo Bertoloui, Massimo Maccherini, GianGastone Neri Serneri, 
University of Florence, Florence, Italy 
Background: Few therapies are known to enhance diastolic function. Systemic adminis- 
tration of natriuretlc peptldes (NP) improves diastolic function. However, this may be due 
to effects on load, rather than a direct myocardlal action. We generated mice with acar- 
disc-specific (a-MHC promoter) gain-of-function mutation (GoF, HCAT E974A) in the 
natriuretic peptide A receptor (NPRA) resulting in myocyte-specific constitutive NPRA 
activation. We hypothesized that GoF mice would exhibit enhanced diastolic function and 
develop less diastolic dysfunction with pressure-overload. 
Methods: GoF mice (n=l2) and their wildtype (WT -/-, n=18) littermates underwent 
abdominal aortic banding to generate pressure-overload hypertrophy. LV structure and 
function (echo, catheterization, autopsy) were assessed three weeks after banding. Non- 
banded GoF (n=15) and Wl -/-(n=l3) groups ware controls. 
Results: See table (mean *SD): With aortic banding, both GoF and WT mice developed 
LV hypertrophy. While load and systolic function were similar between Wl and GoF mice 
without and with banding, the time constant of LV relaxation (Tau) was decreased in GoF 
mice as compared to WT indicating improved diastolic function. 
Conclusion: Chronic cardiac-specific NPRA activation via this GoF mutation enhanced 
diastolic function in mice and markedly attenuated diastolic dysfunction associated with 
pressure-overload hypertrophy. These data suggest that NP improve diastolic function 
via a direct myocardial effect. 
Background The enhanced cardiac angiotensin (Ang) II production in human failing ven- 
tricles is associated with an Increased expression of proinflammatory cytokines. We 
assessed the hypothesis that in failing myocytes the Ang II evoked signalling is read- 
dressed versus the activation of intracellular signaling not elicited in the normal heart. 
Methods Studies were performed on isolated ventricular myocytes (1x10s celVml) 
obtained from 12 heart failure patients who underwent cardiac transplantation and 5 ten- 
tative heart donors. The activation of intracellular kinase pathways (ERKl/P, SAPWJNK 
and JAKP) by Ang II (10 nM) in the presence or in the absence of type 1 (valsartan, 1 ~.IM) 
and type 2 (PDl23319. 1pM) receptor antagonlsts, was investigated by Western blot 
analisis using specific antibodies. 
Results In non failing myocytes Ang II type 1 receptor stimulation significantly activated 
mainly ERKlR and also SAPWJNK pathways but no JAK2 phosphorilation was 
observed. JAKP phosphorilation was induced only by interleukin-8 (100 ng/ml). 
In failing myocyies Ang II mediated ERKlI2 activation was selectively impaired (-88% vs 
controls) with unchanged SAPWJNK stimulation. Differently from controls, in failing myo- 
cytes Ang II caused a significant type 1 receptor mediated increase in JAK2 phosphorila- 
tion. 
Conclusion In conclusion, in falling myocytes Ang II activates different intracellular path- 
ways from normal cells as indicated by the impaired Ang II mediated activation of the 
growth promoting (ERKlI2) signalling with contemporary enhanced activation of the 
proinflammatory (JAK2) pathway. 
Variable HCAT E Control HCAT E Banded 
LV End-diastolic 
dimension, mm 
Fractional Shortening, % 
LV Mass, g 
Heart Rate (anesthesia), 
bpm 
Maximum LV Pressure. 
mmHg 
End-diastolic LV 
Pressure, mmHg 
Tau, msec 
Heart weight I Body 
weight, mg/g 
GoF Littermate P GoF Littermate P 
(+I-) (-I-) Value (+I-) (-I-) VaIlIs 
3.5eO.2 3.4r0.4 0.45 3.7ztO.3 3.5r0.2 0.03 
36*5 34*4 
0.09+0. 0.09*0.02 
02 
450&O 398*45 
94*14 84+14 
6*6 5*6 0.58 7*8 8+5 0.60 
13*2 16i3 0.04 16i4 21*5 
4.2eO.3 4.leO.3 0.36 4.8*1 .O 4.5eO.5 
0.33 
0.55 
0.04 
0.25 96+15 86+12 
33*4 34*3 
0.12*0. 0.11*0.01 
03 
409*72 399*83 
0.89 
0.49 
0.78 
0.07 
0.04 
0.30 
1158-72 Chronic Al and A2b Adenosine Receptor Blockade 
Improves Diabetes and Attenuates Renal and Cardiac 
Histopathology in Animals With the Metabolic 
Syndrome 
Steven P. Tofovic, Eman M. Salah. Glenn Smits, Eric Whalley, Barry Ticho, Edwin K. 
Jackson University of Pittsburgh School of Medicine, Pittsburgh, PA, Biogen, Inc.. -1 
CambrIdge, MA 
Background: In animals and patients with left ventricular dysfunction, short-term Al ade- 
nosine receptor (Al R) blockade causes diuresislnatriuresls without altenng potassium 
excretion and, in contrast to loop diuretics, improves renal function. A2b adenosine 
receptor (A2bR) blockade has an anti-diabetic effect. The purpose of the present study 
was to examine the long-term effects of AlWA2bR blockade in an animal system 
designed to model the complex pathology that characterizes, wtth increasing frequency, 
the modern cardiac patient. 
Methods: BG9928 is a novel, orally active and selective adenoslne receptor antagonist 
which has high affinity for Al R and moderate affinity for A2bR. The ZSFl rat IS a model 
of the metabolic syndrome that expresses obesity, hypertension, type II diabetes, dyslip- 
Idemra, dilated cardiomyopathy and severe nephropathy. BG9928 (10 mg/kgIday). capto- 
pril (100 mglkglday. orally) and furosemide (50 mglkgfday, orally), alone or in 
combination, ware administered for 24 weeks to ZSFl rats (9 or 10 par group). An 
untreated control group was included. 
Results: BG9928 reduced urinary glucose excretion (from 823 +I- 179 to 196 +/- 80 mg/ 
kg/day; P=O.O04) and in some groups attenuated worsening of the oral glucose tolerance 
test and increases in fasting plasma glucose and insulin levels. Chronic captopril doubled 
the urinary excretion rate (P<O.OOl) and the renal interstitial levels (P=O.OOE) of adenos- 
inc. Compared with control animals, BG9928 blocked the age-related increase in plasma 
triglycerides and significantly reduced focal segmental glomerulosclerosis and cardiac 
vasculitisiinflammation. degenerative ischemic changes and necrosis (P<O.O5). At 12 
weeks of treatment, BG9928 Increased captopril- and furosemide-induced ranln release, 
but this effect was lost by 24 weeks into treatment. 
Conclusion: In dilated cardiomyopathy complicated by the metabolic syndrome and renal 
disease, chronic AiR/APbR blockade may improve type II diabetes, lower plasma tnglyc- 
erides and attenuate renal and cardiac histopathology. 
1158-74 New Technique for Measurement of Lefi Ventricular 
Pressure in Conscious Mice: Detection of Persistent 
Hemodynamic Depression for Three Days Post 
Anesthesia 
Shinli Ishlzaka, Richard E. Sievers, Bo-Qtng Zhu, Elyse Foster, Paul C. Simpson, William 
Grossman, University of California San Francisco. San Francisco, CA 
Background: Physiologic studies in transgenic and knockout mice have largely been 
done under anesthesia. Concern about the effects of anesthesia on physiologic mea- 
surements lad us to develop methodology to assess left ventricular (LV) pressure in con- 
SCIOUS mkx?. This studv was desianed to evaluate the new techniaue. and to assess 
acute and persistent effects of anesthesia on LV function in mice.Methcds: PE-50 tub- 
ina filled with heoarinized saline was imolanted in the LV cavitv throuah its aoex via an I 
L  1  
abdominal approach, and exteriorized to the back. This surgery was done under anes- 
thesia with either intraperitoneal injection of k&amine (EOmg/kg) and xylazine (5mg/kg) 
(K+X) in 11 mice or isoflurane (ISF. 1.5 ~01%) by inhalation in 14 mice. Post-operatively, 
mice were trained daily to lie quietly head first in a plastic cone. LV pressure, dP/dt and 
heart rate (HR) in conscious state were compared between the two groups at 3 days and 
1 week following recovery from surgery using a 1.4 F Millar catheter inserted into the LV 
through the tubing with mice lying quietly in the plastic cone. Results: Acutely during 
anesthesia, K+X decreased heart rate (HR) from 698 to 298 bpm (pcO.Ol), LV pressure 
from 107 to 85 mmHg (pcO.01) and maxlmal dP/dt (dP/dh,d from 15,724 to 4,445 
mmHg/sec (p<O.Ol). Moreover, these negative chronotropic and negative inotropic 
effects of K+X were significantly greater than those of ISF. HR and dP/dh,,, were signifi- 
cantly decreased in K+X mice 3 days after surgery compared to ISF (655 vs. 711 bpm; 
~~0.05. 14,448 vs. 18,048 mmHg/sec; p<O.OOl, respectively), and Increased to the same 
level as in ISF mice 1 week after surgery (698 bpm; ns vs. ISF, 17,230 mmHg/sec; ns vs. 
ISF, respectively). In ISF mice, recovery of function occurred rapidly and there were no 
differences in LV variables between 3 days and l-week. Conclusions: LV pressure and 
its derivative can be measured in conscious mice with a catheter inserted through tubing 
implanted permanently in the LV apex. Anesthesia with either K+X. or to a lesser extent 
ISF, depressed LV function acutely. This depression of function perslsted for 3 days after 
surgery with K+X (but not ISF) and did not recover completely until 1 week post-anesthe- 
sia. 
1158-75 Augmenting Renal Function in Experimental 
Congestive Heart Failure by Brain Natriuretic Peptide 
and Lasix 
Alessandro Cataliottb Horng H. Chen, Guide Boerrigter. Lisa C. Costello-Boerrigter, 
Toshihiro Tsuruda, Lorenzo S. Malatino. John C. Burnett, Jr., Mayo Clinic and 
Foundation, Rochester, MN 
Background: Congestive heart failure (CHF) is characterized by avid sodium and water 
retention. While loop diuretics are powerful natriuretic agents, they can reduce glomeru- 
lar filtration rate (GFR) and activate the renin-anglotensin-aldosterone system (RAAS). 
Studies have reported that GFR is a key predictor of mortality in CHF. Therefore, new 
therapeutic strategies are warranted to both minimize side effects of conventional diuret- 
ics and to potentiate their renal actions. Brain natriuretic peptide (BNP) has natriuretic 
and renln inhibiting properties. The diuretic actions of BNP, mainly located in the tubules, 
are associated with preserved GFR. We characterized the renal actions of BNP alone 
and in combination with Lasix (L). We hypothesized that BNP in combination with L main- 
tains GFR and suppresses RAAS. 
Methods: CHF was produced I” two groups of dogs by rapid ventricular pacing (10 days 
at 240 bpm). At day 11 one group received continuous (30 m!n) intravenously adminis- 
tered low dose (2 pmollkglmin) followed by 30 min high dose (10 pmollkg/min) of BNP. A 
second group (BNP+L) of dogs received i.v. co-infusion (60 min) of L (Img/Kg/hr) and 
low and high dose of BNP. ’ Indicates ~~0.05 vs baseline. 
